ClinConnect ClinConnect Logo
Search / Trial NCT03845491

ASSIST Registry Studying Various Operator Techniques

Launched by STRYKER NEUROVASCULAR · Feb 15, 2019

Trial Information

Current as of August 11, 2025

Completed

Keywords

ClinConnect Summary

ASSIST is a prospective, global, consecutive enrollment Registry of anterior circulation acute ischemic stroke patients with an LVO who undergo treatment with one of the interventional techniques using Stryker Neurovascular devices for the first pass. The purpose of this Registry is to assess the procedural success and clinical outcomes associated with various operator techniques for mechanical thrombectomy in large vessel occlusions (LVO) in the anterior circulation. Data will be collected on the use of Stryker market-released neurovascular mechanical access and mechanical thrombectomy dev...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Subjects who experienced acute ischemic stroke (AIS), eligible for restoration of blood flow using Stryker Neurovascular market-released products in the neurovasculature to remove thrombus
  • 2. Occlusion of intracranial anterior circulation vessel
  • 3. Subject or subject's legally authorized representative (LAR) has signed the informed consent form prior to or within 48 hours post-procedure
  • 4. Subject is willing to comply with the protocol follow-up requirements
  • 5. The intended technique and treated technique must be one of the following techniques for the first thrombectomy pass in the neurovasculature per Instructions For Use (IFU): Technique Category/Devices: SR Classic/SR + BGC, SR Combination/SR + Asp Cath ± Pump + BGC or LS, Direct Aspiration/Asp Cath ± Pump + BGC or LS,
  • Exclusion Criteria:
  • The subject is participating in another device trial or any other clinical trial where the study procedure or treatment might confound this study's endpoint.

About Stryker Neurovascular

Stryker Neurovascular is a leading medical technology company focused on developing innovative solutions for the treatment of neurovascular conditions. As a subsidiary of Stryker Corporation, it specializes in advanced products and therapies aimed at improving patient outcomes in the fields of stroke intervention and surgical treatment of neurovascular diseases. With a commitment to research and development, Stryker Neurovascular works collaboratively with healthcare professionals to deliver cutting-edge technologies that enhance procedural efficiency and safety, ultimately striving to transform the standard of care in neurovascular medicine.

Locations

Bronx, New York, United States

Royal Oak, Michigan, United States

Valhalla, New York, United States

Danville, Pennsylvania, United States

Indianapolis, Indiana, United States

Lausanne, , Switzerland

Kansas City, Kansas, United States

Los Angeles, California, United States

Pittsburgh, Pennsylvania, United States

Philadelphia, Pennsylvania, United States

Madrid, , Spain

Providence, Rhode Island, United States

Hollywood, Florida, United States

Madrid, , Spain

Basel, , Switzerland

Santander, , Spain

Charleston, South Carolina, United States

Gwangju, , Korea, Republic Of

Kassel, , Germany

Heidelberg, , Germany

Modesto, California, United States

Gent, , Belgium

Stanford, California, United States

Munich, , Germany

Rouen, , France

Dortmund, , Germany

Toledo, Ohio, United States

Orange, California, United States

New York, New York, United States

Suwon, , Korea, Republic Of

Roma, , Italy

Harlingen, Texas, United States

Jacksonville, Florida, United States

Worcester, Massachusetts, United States

Milwaukee, Wisconsin, United States

Genova, , Italy

Barcelona, , Spain

Toronto, , Canada

Geneva, , Switzerland

Mesa, Arizona, United States

Fontana, California, United States

Los Angeles, California, United States

Rancho Cordova, California, United States

Delray Beach, Florida, United States

Tampa, Florida, United States

Marietta, Georgia, United States

Oak Lawn, Illinois, United States

Flint, Michigan, United States

Lansing, Michigan, United States

Buffalo, New York, United States

Columbus, Ohio, United States

Oklahoma City, Oklahoma, United States

Portland, Oregon, United States

Memphis, Tennessee, United States

El Paso, Texas, United States

Morgantown, Virginia, United States

Ostend, , Belgium

Hradec Králové, , Czechia

Bordeaux, , France

Brest, , France

Bron, , France

Munich, , Germany

Recklinghausen, , Germany

Messina, , Italy

Parma, , Italy

Siena, , Italy

Via Giardini, , Italy

Valladolid, Castilla Leon, Spain

Oviedo, Vigo, Spain

Madrid, , Spain

Palma De Mallorca, , Spain

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Rishi Gupta, MD

Principal Investigator

WellStar Medical Group

Markus Möhlenbruch, MD

Principal Investigator

University Hospital Heidelberg

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials